Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues
Reexamination Certificate
2011-05-31
2011-05-31
Yu, Misook (Department: 1643)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
C424S130100
Reexamination Certificate
active
07951904
ABSTRACT:
The use of monoclonal antibodies to the angiotensin-II type-I receptor is provided for the treatment of cancer and vascular smooth muscle cell proliferation. Specifically, use is provided of a monoclonal antibody or a fragment thereof to a peptide comprising the N-terminal portion of the angiotensin-II type-1 receptor defined by the sequence MILNSSTEDG IKRIQDDCPK AGRHNYIFVM IPTLYSIIFV VGIFG in the preparation of a medicament for the treatment of cancer or in the preparation of a medicament for the treatment of vascular smooth muscle (VSM) cell proliferation.
REFERENCES:
patent: 6063620 (2000-05-01), Vinson et al.
patent: 2093495 (1994-06-01), None
patent: 1141000 (1997-01-01), None
patent: 95/12410 (1995-05-01), None
patent: WO 95/09186 (1999-04-01), None
patent: WO0261087 (2002-08-01), None
patent: WO 2004/018519 (2004-03-01), None
Ezzell (J. NIH Res, 1995, 7:46-49).
Spitler (Cancer Biotherapy, 1995, 10:1- 3).
Boon (Adv Can Res, 1992, 58:177-210).
DeGruijl et al (Nature Medicine, 5410): 1124-1125, Oct. 1999).
Ngo et al., in The Protein Folding Problem and Tertiary Structure Prediction, 1994, Merz, et al., (ed.), Birkhauser, Boston, MA, pp. 433 and 492-495.
Burgess et al., J of Cell Bio. 111:2129-2138, 1990.
(Lazar et al. Molecular and Cellular Biology 8:1247-1252, 1988.
Coleman et al. (Research in Immunology, 1994; 145(1): 33-36).
Abaza et al. (Journal of Protein Chemistry, vol. 11, No. 5, 1992, pp. 433-444, see abstract in particular).
Humphries et al (J. of Tissue Culture Methods, 1994, vol. 16, pp. 239-242).
sequence search result-Vinson, 2010.
sequence search result-Burmer 2010.
Barker et al., “Monoclonal antibody to a conserved sequence in the extracellular domain recognizes the angiotensin II AT1 receptor in mammalian target tissues,”J. of Molecular Endocrinology(1993) 11:241-245.
Cheng et al., “Young SHR express increased type 1 angiotensin II receptors in renal proximal tubule,”Am J Physiol. (1998) 274(1 Pt 2):F10-7.
De Paepe et al., “Growth stimulatory angiotensin II type-1 receptor is upregulated in breast hyperplasia and in situ carcinoma but not in invasive carcinoma,”Histochem Cell Biol(2001) 116:247-254.
Harrison-Bernard et al., “Immunohistochemical localization of ANG II AT1 receptor in adult rat kidney using a monoclonal antibody,”Am J Physiol. (1997) 273(1 Pt 2):F170-7.
Inwang et al., “Angiotensin II type 1 receptor expression in human breast tissues,”J. of Cancer(1997) 75(9):1279-1283.
Kapas et al., “Internalization of the type I angiotensin II receptor (AT1) is required for protein kinase C activation but not for inositol triphosphate release in the angiotensin II stimulated rat adrenal zona glomerulosa cell,”Biochemical and Biophysical Research Communications(1994) 204(3):1292-1298.
Ling et al., “Matrix-dependent gene expression of Egr-1 and PDGF a regulate angiotensin II-induced proliferation in human vascular smooth muscle cells,”Hypertension(1999) 34:1141-1146.
Marsigliate et al., “AT1 angiotensin II receptor subtype in the human larynx and squamous laryngeal carcinoma,”Cancer(1996) 110:19-27.
Murphy et al., “Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor,”Nature(1991) 351:233-236.
Richards et al., “Inhibition of central angiotensin responses by angiotensin type-1 receptor antibody,”Hypertension(1993) 21(6):1062-1065.
Tahmasebi et al., “Transcription of the prorenin gene in normal and diseased breast,”European J. of Cancer(1998) 34(11):1777-1782.
Touyz et al., “Angiotensin II stimulates DNA and protein synthesis in vascular smotth muscle cells from human arteries: role of extracellular signal-regulated kinases,”Hypertension(1999) 17:907-916.
Vinson et al., “Internalisation of the type I angiotensin II receptor (AT1) and angiotensin II function in the rat adrenal zona glomerulose cell,”J. of Endocrinology(1994) 141:R5-R9.
Yang et al., “Involvement of MAP kinase in angiotension II-induced phosphorylation and intracellular targeting of neuronal AT1 receptors,”J. of Neuroscience(1997) 17(5):1660-1669.
Yang et al., “Increased angiotensin II type 1 receptor expression in hypercholesterolemic atherosclerosis in rabbits,”Arterioscler Thromb Vasc Biol. (1998) 18(9):1433-9.
International Search Report dated Apr. 21, 2004 for International Application No. PCT/GB03/03758.
Fujimoto, Y., et al., Angiotension II Type 1 Receptor In Human Pancreatic Cancer ANd Growth Inhibition By Angiotension II Type 1 Receptor Antagonist, FEBS Letters, 2001;495:197-200.
Tamarat, R., et al., Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways, Lab Invest. Jun. 2002;82(6):747-56.
Barker Stewart
Puddefoot John Richard
Vinson Gavin Paul
Pepper Hamilton LLP
Queen Mary & Westfield College
Yao Lei
Yu Misook
LandOfFree
Therapeutic uses of monoclonal antibodies to the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic uses of monoclonal antibodies to the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic uses of monoclonal antibodies to the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2625553